LQLiming Qing

Liming Qing

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Liming Qing has a total of 20 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The global perspective on the evolution of nurse-related research in primary malignant bone tumors from 2004 to 2025

    by Nianzhe Sun, Laiyu Xu, Jinfei Fu, Panfeng Wu, Liming Qing, Lingli Peng, Juyu Tang

    Background: Primary malignant bone tumors, as diseases that mostly occur in adolescence, seriously affect all aspects of the lives of patients and their families. Effective bone tumor nursing is essential to maintain or improve patients’ quality of life. Consequently, investigating bone tumor nursing is of utmost importance. This study aimed to provide a comprehensive, up-to-date synthesis of all published bone tumor nursing research articles and predict future areas of research and emerging trends. Methods: A bibliometric analysis was conducted using the Web of Science Core Collection to identify and analyze nursing research publications on primary malignant bone tumors from January 1, 2004, to September 12, 2025. The analysis and visualization were performed using various scientometric tools. Key characteristics of the publications, including country of origin, institutions, authors, journals, keywords, and references, were thoroughly examined. Results: A total of 686 studies were included in the analysis, with 5376 authors, 70 countries, and 1422 institutions publishing research focused on nurse-related studies in primary malignant bone tumors. The United States and Memorial Sloan Kettering Cancer Center led the lists of publications. The most prolific cited and co-cited authors were Oeffinger, Kevin C, and Bacci, G, respectively. Pediatric Blood & Cancer published the most articles, whereas Journal of Clinical Oncology was the most frequently cited journal. The analysis of keyword co-occurrence and literature co-citation identified several emerging hotspots and trends in the field of primary malignant bone tumor nursing, including prognostic evaluation, clinical intervention, and subtype-targeted nursing care. Conclusion: In recent years, the advancement in nurse-related research in primary malignant bone tumors has accelerated rapidly. A comprehensive bibliometric analysis was utilized to verify the prominent areas of investigation and anticipate future research directions, with the aim of providing valuable insights and recommendations for future studies.

  • Open Access

    Hypoxic mesenchymal stem cell-derived exosomes promote the survival of skin flaps after ischaemia–reperfusion injury via mTOR/ULK1/FUNDC1 pathways

    by Chao Deng, Kangkang Dong, Yongjun Liu, Ken Chen, Chuwei Min, Zheming Cao, Panfeng Wu, Gaojie Luo, Gechang Cheng, Liming Qing, et al.

    Flap necrosis, the most prevalent postoperative complication of reconstructive surgery, is significantly associated with ischaemia–reperfusion injury. Recent research indicates that exosomes derived from bone marrow mesenchymal stem cells (BMSCs) hold potential therapeutic applications in several diseases. Traditionally, BMSCs are cultured under normoxic conditions, a setting that diverges from their physiological hypoxic environment in vivo. Consequently, we propose a method involving the hypoxic preconditioning of BMSCs, aimed at exploring the function and the specific mechanisms of their exosomes in ischaemia–reperfusion skin flaps. This study constructed a 3 × 6 cm2 caudal superficial epigastric skin flap model and subjected it to ischaemic conditions for 6 h. Our findings reveal that exosomes from hypoxia-pretreated BMSCs significantly promoted flap survival, decrease MCP-1, IL-1β, and IL-6 levels in ischaemia–reperfusion injured flap, and reduce oxidative stress injury and apoptosis. Moreover, results indicated that Hypo-Exo provides protection to vascular endothelial cells from ischaemia–reperfusion injury both in vivo and in vitro. Through high-throughput sequencing and bioinformatics analysis, we further compared the differential miRNA expression profiles between Hypo-Exo and normoxic exosomes. Results display the enrichment of several pathways, including autophagy and mTOR. We have also elucidated a mechanism wherein Hypo-Exo promotes the survival of ischaemia–reperfusion injured flaps. This mechanism involves carrying large amounts of miR-421-3p, which target and regulate mTOR, thereby upregulating the expression of phosphorylated ULK1 and FUNDC1, and subsequently further activating autophagy. In summary, hypoxic preconditioning constitutes an effective and promising method for optimizing the therapeutic effects of BMSC-derived exosomes in the treatment of flap ischaemia–reperfusion injury.


  • Open Access

    Knowledge mapping and emerging trends of ferroptosis in ischemia reperfusion injury research: A bibliometric analysis (2013–2022)

    by Nianzhe Sun, Yixuan Xing, Junjie Jiang, Panfeng Wu, Liming Qing, Juyu Tang


  • Open Access

    Ilizarov Bone Transfer for Treatment of Large Tibial Bone Defects: Clinical Results and Management of Complications

    by Zheming Cao, Yiqian Zhang, Katelyn Lipa, Liming Qing, Panfeng Wu, Juyu Tang

    Backgrounds: The purpose of this study is to present our clinical experience using the Ilizarov bone transfer technique and free-flap technique in the reconstruction of large tibial bone and soft tissue defects, including an evaluation of both the management of postoperative complications and long-term outcomes. Methods: From January 2010 to May 2020, 72 patients with tibia bone and soft tissue defects were retrospectively evaluated. Either an anterolateral thigh perforator flaps (ALTP) or latissimus dorsi musculocutaneous flaps (LD), solely or in combination, were used to cover soft tissue defects. Once the flap was stabilized, an Ilizarov external fixator was applied to the limb. Follow-up was postoperatively performed at 1, 3, 6, 9, and 12 months. Results: Postoperatively, there were two cases of total and five of partial flap necrosis, and two cases of subcutaneous ulcers, which were caused by vascular crisis, infection, and hematoma, respectively. All the patients underwent Ilizarov external fixator surgery after flap recovery. A total of 16 complications occurred, including 3 cases of simple needle tract infection (antibiotic treatment) and 13 cases of complications requiring reoperation. A correlation factor analysis revealed that the main factors affecting the healing time were the defect length and operative complications. All patients with complications treated with the vascularized iliac flap eventually healed completely. Conclusions: The Ilizarov method used together with an ALTP, LD, or a combination thereof yields good clinical results for repairing large bone and soft tissue defects of the tibia, thus reducing the incidence of amputations. However, longer treatment times may be involved, and postoperative complications can occur. The vascularized iliac flap may be a suitable choice for the treatment of postoperative complications of this type of Ilizarov bone transport.